We are a highly focused research support oriented company established in 2009. We’re a company that supports the toughest challenges of pharmaceutical and clinical research. We do more than consulting — we aim to make a remarkable impact on pharmaceutical and clinical research services. To achieve this mission, we’ve built a strong foundation. Our experts supported by young energetic team, has proven to be responsive and scaleable through exponential growth since our inception in 2009.


Below is the glimpse of our opinion on current Pharmaceutical affairs and our business updates.

ICH’s Approach to Harmonize Generic Drug Standards

Bioequivalence studies in Humans

WHY Third Party Auditing-Monitoring in Clinical Research?


Business Update
  • We are attending CPhI China 2019 from 18th to 20th June, 2019.
Recent Conference
  • Pharmazone – DIA successfully concluded our first ever “Bioequivalence Bioavailability Congress”- New Paradigms in Generic Drug Development on 11th  & 12th  April 2019 at Ahmedabad, India.

New Awards
  • Presented the “Brand Leadership Award” under Gujarat Brand Leadership Awards 2018.
  • Recognized by one of the most reputed healthcare magazine- Silicon India under “10 Most Promising Clinical Trials Solution Providers – 2018”